Bay Bioanalytical Laboratory Provides Biomarker Support to Successful…

BBL, recently acquired by Pacific BioLabs, contributed to a successful orphan drug Phase 3 trial of BioMarin's GALNS for Morquio Syndrome.

(PRWeb January 28, 2013)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!